HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment with tocilizumab leads to the disappearance of olecranon rheumatoid nodules.

AuthorsHaider M Al Attia, Mohamed Abushawish
JournalInternational journal of dermatology (Int J Dermatol) Vol. 51 Issue 2 Pg. 197-8 (Feb 2012) ISSN: 1365-4632 [Electronic] England
PMID21913909 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab
Topics
  • Adult
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Female
  • Humans
  • Olecranon Process
  • Rheumatoid Nodule (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: